Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Research output: Contribution to journal › Journal article › Research › peer-review
The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients' electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.
| Original language | English |
|---|---|
| Journal | Breast |
| Volume | 25 |
| Issue number | 2 |
| Pages (from-to) | 269-272 |
| ISSN | 0960-9776 |
| DOIs | |
| Publication status | Published - 2019 |
- PRO-CTCAE, adjuvant chemotherapy, breast cancer, patient reported outcome, toxicity, Humans, Hospitalization, Neutropenia/chemically induced, Randomized Controlled Trials as Topic, Denmark, Female, Chemotherapy, Adjuvant/adverse effects, Breast Neoplasms/drug therapy, Patient Reported Outcome Measures
Research areas
ID: 56584193